{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:21:58Z","timestamp":1740108118432,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00347-020-01164-9","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T14:02:31Z","timestamp":1594216951000},"page":"590-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ophthalmologische Erstmanifestation einer letalen Grunderkrankung","Initial ophthalmic manifestation of a\u00a0fatal underlying disease"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3106-5985","authenticated-orcid":false,"given":"J.","family":"Orphal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Terai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"issue":"4","key":"1164_CR1","doi-asserted-by":"publisher","first-page":"107327481772990","DOI":"10.1177\/1073274817729901","volume":"24","author":"C Bohra","year":"2017","unstructured":"Bohra\u00a0C, Sokol\u00a0L, Dalia\u00a0S (2017) Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review. Cancer Control 24(4):1073274817729901","journal-title":"Cancer Control"},{"issue":"2","key":"1164_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/13550289909021994","volume":"5","author":"R Caldarelli-Stefano","year":"1999","unstructured":"Caldarelli-Stefano\u00a0R, Vago\u00a0L, Omodeo-Zorini\u00a0E, Mediati\u00a0M, Losciale\u00a0L, Nebuloni\u00a0M et al (1999) Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals. J\u00a0Neurovirol 5(2):125\u2013133","journal-title":"J Neurovirol"},{"issue":"6","key":"1164_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1756285615602832","volume":"8","author":"D Pavlovic","year":"2015","unstructured":"Pavlovic\u00a0D, Patera\u00a0AC, Nyberg\u00a0F, Gerber\u00a0M, Liu\u00a0M (2015) Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Disord 8(6):255\u2013273","journal-title":"Ther Adv Neurol Disord"},{"key":"1164_CR4","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s13365-018-0637-1","volume":"24","author":"JR Berger","year":"2018","unstructured":"Berger\u00a0JR, Malik\u00a0V, Lacey\u00a0S, Brunetta\u00a0P, Lehane\u00a0PB (2018) Correction to: progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a\u00a0rare event. J\u00a0Neurovirol 24:332","journal-title":"J Neurovirol"},{"key":"1164_CR5","first-page":"23","volume":"137","author":"KB Alstadhaug","year":"2017","unstructured":"Alstadhaug\u00a0KB, Myhr\u00a0K\u2011M, Rinaldo\u00a0CH (2017) Progressive multifocal leukoencephalopathy. Tidsskr Nor Laegeforen 137:23\u201324","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"4","key":"1164_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/ene.13906","volume":"26","author":"T Bartsch","year":"2019","unstructured":"Bartsch\u00a0T, Rempe\u00a0T, Leypoldt\u00a0F, Riedel\u00a0C, Jansen\u00a0O, Berg\u00a0D et\u00a0al (2019) The spectrum of progressive multifocal leukoencephalopathy: a\u00a0practical approach. Eur J Neurol 26(4):566\u2013e41","journal-title":"Eur J Neurol"},{"issue":"10","key":"1164_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40261-016-0433-8","volume":"36","author":"Y Jamilloux","year":"2016","unstructured":"Jamilloux\u00a0Y, Kerever\u00a0S, Ferry\u00a0T, Broussolle\u00a0C, Honnorat\u00a0J, Seve\u00a0P (2016) Treatment of progressive multifocal leukoencephalopathy with mirtazapine. Clin Drug Investig 36(10):783\u2013789","journal-title":"Clin Drug Investig"},{"issue":"10","key":"1164_CR8","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/598335","volume":"48","author":"N Khanna","year":"2009","unstructured":"Khanna\u00a0N, Elzi\u00a0L, Mueller\u00a0NJ, Garzoni\u00a0C, Cavassini\u00a0M, Fux\u00a0CA et\u00a0al (2009) Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 48(10):1459\u20131466","journal-title":"Clin Infect Dis"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01164-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-020-01164-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01164-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T23:55:03Z","timestamp":1625702103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-020-01164-9"}},"subtitle":["Stellenwert der Perimetrie bei unspezifischer Sehverschlechterung","Importance of perimetry in unspecific visual deterioration"],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1164"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01164-9","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"type":"print","value":"0941-293X"},{"type":"electronic","value":"1433-0423"}],"subject":[],"published":{"date-parts":[[2020,7,8]]},"assertion":[{"value":"8 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Orphal und N.\u00a0Terai geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}